Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-15 5:02 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,984,681 (Position Closed) | View |
| 2023-03-13 4:30 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,418,962 5.94% | 1,818,962 (+69.96%) | View |
| 2023-02-14 4:45 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.2% | -1,629,747 (-29.03%) | View |
| 2023-02-14 3:22 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 3,555,992 5.54% | -211,900 (-5.62%) | View |
| 2023-02-14 1:39 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 6,412,000 9.99% | 2,334,000 (+57.23%) | View |
| 2023-02-14 08:59 am Purchase | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 4,582,000 7.14% | 1,146,800 (+33.38%) | View |
| 2023-02-10 5:27 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | GOLDMAN SACHS GROUP INC GS | 3,142,175 4.9% | -1,457,104 (-31.68%) | View |
| 2023-02-10 11:50 am Purchase | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 5,091,285 7.9% | 1,075,127 (+26.77%) | View |
| 2023-02-09 11:35 am Sale | 13G | Travere Therapeutics, Inc. TVTX | VANGUARD GROUP INC | 3,515,446 5.48% | -365,427 (-9.42%) | View |
| 2023-02-09 11:04 am Sale | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,600,000 4.05% | -1,327,000 (-33.79%) | View |
| 2023-02-06 2:55 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 4,224,024 6.58% | 4,224,024 (New Position) | View |
| 2023-02-03 4:27 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 5,194,785 8.1% | 679,640 (+15.05%) | View |
| 2022-10-28 4:30 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,927,000 6.14% | 2,624,508 (+201.50%) | View |
| 2022-05-16 4:55 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 3,435,200 5.41% | 985,200 (+40.21%) | View |
| 2022-02-14 5:22 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 4,078,000 6.7% | 4,078,000 (New Position) | View |
| 2022-02-14 4:50 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | PERCEPTIVE ADVISORS LLC | 1,845,555 3% | -1,648,052 (-47.17%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 5,614,428 9.2% | 1,056,561 (+23.18%) | View |
| 2022-02-14 10:24 am Purchase | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 3,767,892 6.15% | 1,003,970 (+36.32%) | View |
| 2022-02-14 09:01 am Sale | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 2,450,000 4% | -640,200 (-20.72%) | View |
| 2022-02-10 5:22 pm Sale | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 4,016,158 6.6% | -67,395 (-1.65%) | View |